Literature DB >> 7729945

HPV infection in cervical-cancer cases in Russia.

E V Samoylova1, G O Shaikhaiev, S V Petrov, N P Kisseljova, F L Kisseljov.   

Abstract

The presence of human papillomavirus (HPV) sequences in 21 biopsies from cervical carcinomas, 11 specimens of tissues adjacent to tumours, 2 specimens of cervical tissues with radiation fibrosis from patients after radiation therapy of cervical cancer and 7 normal epithelial tissues from the patients with other genital tumours were examined by polymerase chain reaction (PCR) and Southern-blot analysis. All tumours were HPV-positive by type-specific PCR and 86% by Southern-blot analysis. In normal epithelial and adjacent tissues, HPV sequences were detected in 20% of samples by Southern-blot analysis and in 70% of samples by PCR, including 2 cases of tissues after radiation therapy. HPV16 was the most prevalent type in tumours (18/21) as well as in normal epithelial tissues (5/7). One HPV-positive tumour contained HPV18 DNA and 2 were doubly infected with HPVs 16 and 18 (2/21). The persistence of exclusively episomal HPV16 DNA was observed in 5 out of 11 tumours examined: 3 cases of squamous-cell carcinomas on the early stage of tumour progression and 2 advanced tumours (squamous-cell carcinoma and adenocarcinoma). The integration of HPV16 genome was detected in 6 out of 11 tumours, but most of them contained episomal forms of viral DNA simultaneously (5 out of 6). The integrative HPV18 genome was found in 2 tumours examined, and the persistence of episomal forms was also observed in one of them. Our data demonstrate that cervical tumours are associated invariably with high-risk types of HPV in Russia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729945     DOI: 10.1002/ijc.2910610311

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Telomerase as a potential marker for early diagnosing cervical carcinoma.

Authors:  D A Skvortsov; N M Gasparian; M P Rubtsova; M E Zvereva; M D Fedorova; L S Pavlova; A A Bogdanov; O A Dontsova; F L Kisseljov
Journal:  Dokl Biochem Biophys       Date:  2006 May-Jun       Impact factor: 0.788

2.  High risk HPV types in southern Iranian patients with cervical cancer.

Authors:  S Farjadian; E Asadi; M Doroudchi; A Samsami Dehaghani; S Z Tabei; V P Kumar; A Ghaderi
Journal:  Pathol Oncol Res       Date:  2003-07-14       Impact factor: 3.201

3.  Clonality analysis of synchronous lesions of cervical carcinoma based on X chromosome inactivation polymorphism, human papillomavirus type 16 genome mutations, and loss of heterozygosity.

Authors:  Xinrong Hu; Tianyun Pang; Anna Asplund; Jan Pontén; Monica Nistér
Journal:  J Exp Med       Date:  2002-04-01       Impact factor: 14.307

4.  Human papilloma viruses and cervical tumours: mapping of integration sites and analysis of adjacent cellular sequences.

Authors:  Eugene Klimov; Svetlana Vinokourova; Elena Moisjak; Elian Rakhmanaliev; Vera Kobseva; Laimonis Laimins; Fjodor Kisseljov; Galina Sulimova
Journal:  BMC Cancer       Date:  2002-10-13       Impact factor: 4.430

5.  Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer.

Authors:  Tatyana Ivanova; Anatolii Petrenko; Tatyana Gritsko; Svetlana Vinokourova; Ernest Eshilev; Vera Kobzeva; Fjodor Kisseljov; Natalia Kisseljova
Journal:  BMC Cancer       Date:  2002-03-21       Impact factor: 4.430

6.  HPV16 E6 gene variations in invasive cervical squamous cell carcinoma and cancer in situ from Russian patients.

Authors:  X Hu; T Pang; Z Guo; N Mazurenko; F Kisseljov; J Pontén; M Nistér
Journal:  Br J Cancer       Date:  2001-03-23       Impact factor: 7.640

7.  Hypermethylation of genomic 3.3-kb repeats is frequent event in HPV-positive cervical cancer.

Authors:  Alexey N Katargin; Larissa S Pavlova; Fjodor L Kisseljov; Natalia P Kisseljova
Journal:  BMC Med Genomics       Date:  2009-05-27       Impact factor: 3.063

8.  Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells.

Authors:  Galina Volgareva; Larisa Zavalishina; Yulia Andreeva; Georgy Frank; Ella Krutikova; Darya Golovina; Alexander Bliev; Dimitry Spitkovsky; Valeriya Ermilova; Fjodor Kisseljov
Journal:  BMC Cancer       Date:  2004-08-31       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.